181 related articles for article (PubMed ID: 17884821)
1. Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption.
Yeo H; Beck LH; Thompson SR; Farach-Carson MC; McDonald JM; Clemens TL; Zayzafoon M
J Biol Chem; 2007 Nov; 282(48):35318-27. PubMed ID: 17884821
[TBL] [Abstract][Full Text] [Related]
2. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
[TBL] [Abstract][Full Text] [Related]
3. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.
Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC
J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845
[TBL] [Abstract][Full Text] [Related]
5. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
6. Runx1-mediated regulation of osteoclast differentiation and function.
Soung do Y; Kalinowski J; Baniwal SK; Jacome-Galarza CE; Frenkel B; Lorenzo J; Drissi H
Mol Endocrinol; 2014 Apr; 28(4):546-53. PubMed ID: 24606124
[TBL] [Abstract][Full Text] [Related]
7. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast menin regulates bone mass in vivo.
Kanazawa I; Canaff L; Abi Rafeh J; Angrula A; Li J; Riddle RC; Boraschi-Diaz I; Komarova SV; Clemens TL; Murshed M; Hendy GN
J Biol Chem; 2015 Feb; 290(7):3910-24. PubMed ID: 25538250
[TBL] [Abstract][Full Text] [Related]
9. The LIM protein LIMD1 influences osteoblast differentiation and function.
Luderer HF; Bai S; Longmore GD
Exp Cell Res; 2008 Sep; 314(15):2884-94. PubMed ID: 18657804
[TBL] [Abstract][Full Text] [Related]
10. The Protective Effects of Calcineurin on Pancreatitis in Mice Depend on the Cellular Source.
Wen L; Javed TA; Dobbs AK; Brown R; Niu M; Li L; Khalid A; Barakat MT; Xiao X; Yimlamai D; Konnikova L; Yu M; Byersdorfer CA; Husain SZ
Gastroenterology; 2020 Sep; 159(3):1036-1050.e8. PubMed ID: 32445858
[TBL] [Abstract][Full Text] [Related]
11. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
[TBL] [Abstract][Full Text] [Related]
12. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation.
Xiao Z; Zhang S; Cao L; Qiu N; David V; Quarles LD
J Biol Chem; 2010 Jan; 285(2):1177-87. PubMed ID: 19887454
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.
Oshima K; Nampei A; Matsuda M; Iwaki M; Fukuhara A; Hashimoto J; Yoshikawa H; Shimomura I
Biochem Biophys Res Commun; 2005 Jun; 331(2):520-6. PubMed ID: 15850790
[TBL] [Abstract][Full Text] [Related]
14. CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.
Ruiz P; Martin-Millan M; Gonzalez-Martin MC; Almeida M; González-Macias J; Ros MA
Sci Rep; 2016 Nov; 6():36201. PubMed ID: 27804995
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
16. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
19. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
[TBL] [Abstract][Full Text] [Related]
20. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
